Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 119 citing articles:

The Nucleus Accumbens: Mechanisms of Addiction across Drug Classes Reflect the Importance of Glutamate Homeostasis
Michael D. Scofield, Jasper A. Heinsbroek, Cassandra D. Gipson, et al.
Pharmacological Reviews (2016) Vol. 68, Iss. 3, pp. 816-871
Open Access | Times Cited: 527
Medication-Assisted Treatment of Opioid Use Disorder
Hilary S. Connery
Harvard Review of Psychiatry (2015) Vol. 23, Iss. 2, pp. 63-75
Open Access | Times Cited: 496
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism
Nolan Williams, Boris D. Heifets, Christine Blasey, et al.
American Journal of Psychiatry (2018) Vol. 175, Iss. 12, pp. 1205-1215
Open Access | Times Cited: 416
The effects of Δ9-tetrahydrocannabinol on the dopamine system
Michael Bloomfield, Hulegar A. Abhishekh, Nora D. Volkow, et al.
Nature (2016) Vol. 539, Iss. 7629, pp. 369-377
Open Access | Times Cited: 301
Making Sense of Rodent Models of Anhedonia
Simona Scheggi, Maria Graziella De Montis, Carla Gambarana
The International Journal of Neuropsychopharmacology (2018) Vol. 21, Iss. 11, pp. 1049-1065
Open Access | Times Cited: 169
Ketamine: A tale of two enantiomers
Luke A. Jelen, Allan H. Young, James Stone
Journal of Psychopharmacology (2020) Vol. 35, Iss. 2, pp. 109-123
Open Access | Times Cited: 163
Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: Current understanding and approaches to management
Joseph V. Pergolizzi, Robert B. Raffa, Melanie Rosenblatt
Journal of Clinical Pharmacy and Therapeutics (2020) Vol. 45, Iss. 5, pp. 892-903
Open Access | Times Cited: 160
Transcriptional Alterations in Dorsolateral Prefrontal Cortex and Nucleus Accumbens Implicate Neuroinflammation and Synaptic Remodeling in Opioid Use Disorder
Marianne L. Seney, Sam-Moon Kim, Jill R. Glausier, et al.
Biological Psychiatry (2021) Vol. 90, Iss. 8, pp. 550-562
Open Access | Times Cited: 113
Reversal of morphine-induced cell-type–specific synaptic plasticity in the nucleus accumbens shell blocks reinstatement
Matthew C. Hearing, Jakub Jedynak, Stephanie R. Ebner, et al.
Proceedings of the National Academy of Sciences (2016) Vol. 113, Iss. 3, pp. 757-762
Open Access | Times Cited: 148
Glutamatergic transmission in drug reward: implications for drug addiction
Manoranjan S. D’Souza
Frontiers in Neuroscience (2015) Vol. 9
Open Access | Times Cited: 132
Opioid Release after High-Intensity Interval Training in Healthy Human Subjects
Tiina Saanijoki, Lauri Tuominen, Jetro J. Tuulari, et al.
Neuropsychopharmacology (2017) Vol. 43, Iss. 2, pp. 246-254
Open Access | Times Cited: 109
Targeting opioid dysregulation in depression for the development of novel therapeutics
Caroline A. Browne, Irwin Lucki
Pharmacology & Therapeutics (2019) Vol. 201, pp. 51-76
Open Access | Times Cited: 84
Ketamine for depression
Luke A. Jelen, James Stone
International Review of Psychiatry (2021) Vol. 33, Iss. 3, pp. 207-228
Closed Access | Times Cited: 70
The opioid system in depression
Luke A. Jelen, James Stone, Allan H. Young, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 140, pp. 104800-104800
Open Access | Times Cited: 49
Opioid and Psychostimulant Plasticity: Targeting Overlap in Nucleus Accumbens Glutamate Signaling
Matthew C. Hearing, Nicholas Graziane, Yan Dong, et al.
Trends in Pharmacological Sciences (2018) Vol. 39, Iss. 3, pp. 276-294
Open Access | Times Cited: 77
Dopamine D2/3- and μ-opioid receptor antagonists reduce cue-induced responding and reward impulsivity in humans
Susanna Weber, Beatrice Beck‐Schimmer, M-E Kajdi, et al.
Translational Psychiatry (2016) Vol. 6, Iss. 7, pp. e850-e850
Open Access | Times Cited: 75
Morphine disinhibits glutamatergic input to VTA dopamine neurons and promotes dopamine neuron excitation
Ming Chen, Yanfang Zhao, Hualan Yang, et al.
eLife (2015) Vol. 4
Open Access | Times Cited: 73
Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine
Chloe J. Jordan, Jianjing Cao, Amy Hauck Newman, et al.
Neuropharmacology (2019) Vol. 158, pp. 107609-107609
Open Access | Times Cited: 62
Beyond the 5-HT2AReceptor: Classic and Nonclassic Targets in Psychedelic Drug Action
Lindsay P. Cameron, Joseph Benetatos, Vern Lewis, et al.
Journal of Neuroscience (2023) Vol. 43, Iss. 45, pp. 7472-7482
Open Access | Times Cited: 21
Cell-type and region-specific nucleus accumbens AMPAR plasticity associated with morphine reward, reinstatement, and spontaneous withdrawal
Aric Madayag, Devan M. Gomez, Eden M. Anderson, et al.
Brain Structure and Function (2019) Vol. 224, Iss. 7, pp. 2311-2324
Open Access | Times Cited: 47
Clinical Pharmacology, Toxicity, and Abuse Potential of Opioids
David Vearrier, Oliver Grundmann
The Journal of Clinical Pharmacology (2021) Vol. 61, Iss. S2
Open Access | Times Cited: 39
Addictive drugs modify neurogenesis, synaptogenesis and synaptic plasticity to impair memory formation through neurotransmitter imbalances and signaling dysfunction
Ameneh Rezayof, Zahra Ghasemzadeh, Oveis Hosseinzadeh Sahafi
Neurochemistry International (2023) Vol. 169, pp. 105572-105572
Closed Access | Times Cited: 13
Spontaneous oxycodone withdrawal disrupts sleep, diurnal, and electrophysiological dynamics in rats
Michael Gulledge, William A. Carlezon, R. Kathryn McHugh, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0312794-e0312794
Open Access
Addiction and stress: Exploring the reward pathways in brain affected by different drugs
Samira Rostami Mehr, Babak Nakhaei, Hossein Soleimani, et al.
Progress in brain research (2025)
Closed Access
Intranasal overdose reversal formulations: a rapid review of available agents
Kimberly Bernosky‐Smith, Orian Painter, Stephen Butler, et al.
Pain Management (2025), pp. 1-9
Closed Access
Page 1 - Next Page

Scroll to top